Form4insider filings, from the source

SEC Form 4/A · accession 0001192482-19-000091

Recro Pharma, Inc. · REPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Michael Celano
Officer — Chief Operating Officer
Period of report
Jan 18, 2019
Accepted (ET)
Feb 19, 2019 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F6Jan 18, 2019A14,464$0.00A41,237D
Common StockF2Jan 18, 2019M6,400—A47,637D
Common StockF3Jan 18, 2019F1,782$7.99D45,855D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F6,F4$7.99Jan 18, 2019A67,500A—Jan 18, 2029Common Stock67,50067,500D
Restricted Stock UnitsF2,F5—Jan 18, 2019M6,400D——Common Stock6,40012,800D

Explanation of responses